GMP Question & Answer Guide

Posted on

 

GMP Question & Answer Guide
The requirements defined in the GMP Guidelines often leave room for interpretation. However, regulators worldwide (EMA, FDA, TGA etc) sometimes publish frequently asked questions on GMP. In a new ECA document these Q&As are summarized in a single source. The Q&As are structured in 4 main GMP Areas (General GMPs, GMP for APIs, GMP for Medicinal Products, GMP for IMPs). The document contains 150 pages of Q&As and is available at no cost on the ECA Webpage. A first set of ECA Q&As have also been included and additional GMP Q&As are planned for the future. Here you can access the GMP Questions and Answers Guide

http://www.gmp-compliance.org/eca_gmp-guide.html

GMP Question and Answer Guide „GMP Advisor“
  http://www.gmp-compliance.org/eca_gmp-guide.html
Searching for concrete answers to GMP questions is a time-consuming activity. The document we now offer is intended to provide a single source of information. We have summarized GMP questions and answers from regulators around the world.

In addition to EMA, FDA, Health Canada, MHRA (UK), TGA (Australia) and ICH, we have also used Q&As from ECA. The subject index of the document contains some of the “GMP Key Words” and enables the finding of Q&As addressing the relevant topic. It is intended to update this comprehensive collection and to also add new Q&As once they are available.

The document is structured into the 4 main GMP areas: General GMPs (applicable to medicinal products, APIs and IMPs), GMP for Medicinal Products, GMP for APIs and GMP for Investigational Medicinal Products (IMPs). In addition,it is indicated which organization has issued the Question and Answers. You can access and download the GMP Q&A Guide here

Please see the table of contents below:

1. General GMPs
1.1 EMA Europe
1.1.1 General
1.1.2 EU GMP Annex 1 Sterile Products
1.1.3 EU GMP Annex 6: Manufacture of medicinal gases
1.1.4 EU GMP Annex 8: Sampling
1.1.5 EU GMP Annex 11: Computerised systems
1.1.6 EU GMP Annex 16 QP and Batch Release
1.1.7 EU GMP Annex 19 Reference Standards
1.1.8 Impurities
1.2 MHRA (Europe/UK)
1.2.1Quality Risk Management
1.2.2 Out of Specification
1.3 ECA Academy (Europe)
1.3.1 EU GMP Annex 11: Computerised System
1.4 FDA (USA)
1.4.1 General GMP
1.5 Health Canada
1.5.1 General Issues
1.5.2 Sterile Products
1.6. TGA Australia
1.6.1 General Issues
1.6.9 Reference and retention samples (Annex 19)
1.7 ICH
1.7.1 ICH: Q8, Q9 and Q10
1.7.2 FDA and EMA on Design Space Verification

2. GMP for Medicinal Products
2.1 EU GMP (EMA)
2.2. TAG Australia

2.2.1 Manufacture of sterile medicinal products (Annex 1)
2.2.2 Manufacture of biological medicinal products (Annex 2)
2.2.3 Manufacture of radiopharmaceuticals (Annex 3)
2.2.4 Manufacture of herbal medicinal products (Annex 7)
2.2.5 Sampling of starting and packaging materials (Annex 8)
2.2.6 Qualification and validation (Annex 15)

3. GMP for APIs
3.1 EU GMP (EMA)
3.2 EU GMP (MHRA/UK)

4. GMP for IMPs
4.1. EU GMP (EMA)
4.2 EU GMP (MHRA/UK)
4.3 TGA Australia

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s